Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pontifax Venture Capital is a healthcare-dedicated venture capital firm founded in 2004, with offices in Tel Aviv and Boston. The firm manages $1.2 billion in assets under management (AUM) and has built a portfolio of approximately 100 companies. Co-founded by Eli Hurvitz, a significant figure in the growth of Teva Pharmaceuticals, Pontifax focuses on transformative life sciences technologies across all development stages.
Since its inception, Pontifax has evolved to include an AgTech arm, Pontifax Global Food and Agriculture, expanding its investment scope beyond traditional healthcare. The firm is committed to sourcing disruptive ideas and providing hands-on guidance to maximize the success of its portfolio companies, which address significant unmet needs in the healthcare sector.
Pontifax Venture Capital invests in breakthrough innovations in life sciences, encompassing sectors such as biotech, healthcare, digital health, and agtech. The firm targets companies at various stages, including pre-seed, seed, seed+, Series A, Series B, Series C, and growth equity. This broad investment strategy allows Pontifax to engage with startups at critical points in their development.
The firm emphasizes sourcing disruptive ideas and building companies that can deliver transformative solutions. Pontifax provides strategic direction, capital markets expertise, and mergers and acquisitions support, ensuring that its portfolio companies are well-positioned for success in a competitive landscape.
Pontifax's portfolio includes approximately 100 companies that develop solutions to significant unmet needs in the healthcare sector. While specific names and outcomes of portfolio companies were not disclosed, the firm is known for its focus on clinical-stage companies and those innovating in life sciences. The diverse range of companies reflects Pontifax's commitment to addressing various challenges within healthcare and life sciences.
Additionally, the inclusion of an AgTech arm indicates Pontifax's interest in agricultural technologies that intersect with health and sustainability, further broadening its investment horizon.
Eli Hurvitz - Co-founder and Chairman. Eli Hurvitz was instrumental in the growth of Teva Pharmaceuticals, bringing significant expertise in the life sciences sector to Pontifax. His leadership has shaped the firm's investment strategy and focus on transformative healthcare solutions.
Startups should pitch to Pontifax through their website at pontifax.com. It is recommended to include a comprehensive deck that outlines the business model, market opportunity, and team expertise. Response times may vary, so founders should be prepared for potential follow-up discussions.
As of March 2026, Pontifax Venture Capital continues to manage $1.2 billion in assets and maintains a portfolio of approximately 100 companies. The firm remains focused on transformative life sciences technologies and actively seeks new investment opportunities in the healthcare sector.
What are Pontifax's investment criteria?
Pontifax focuses on breakthrough innovations in life sciences across all development stages, including pre-seed, seed, and growth equity. The firm seeks companies that address significant unmet needs in healthcare and are capable of delivering transformative solutions.
How can startups apply or pitch to Pontifax?
Startups interested in pitching to Pontifax should visit their website at pontifax.com. Specific application forms or processes are not detailed, but the website serves as the primary channel for submissions.
What makes Pontifax different from other venture capital firms?
Pontifax distinguishes itself through its deep expertise in life sciences and its hands-on approach to supporting portfolio companies. The firm provides strategic direction, capital markets expertise, and mergers and acquisitions support, which are critical for startups navigating complex healthcare markets.
What is the geographic scope of Pontifax's investments?
Pontifax primarily invests in the United States, focusing on healthcare and life sciences innovations that can have a significant impact on the market.
What is the typical check size for investments?
While specific check sizes are not disclosed, Pontifax invests across various stages, indicating a flexible approach to funding that can accommodate different company needs.
What kind of post-investment involvement does Pontifax have?
Pontifax is known for providing hands-on guidance and strategic support to its portfolio companies, helping them navigate challenges and maximize their potential for success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.